ClinicalTrials.gg
CompletedNCT03867019Updated Jan 13, 2021

The Cardiac Autonomic Control System Response to Vestibular Stimulation in Subjects With and Without BPPV

An observational study in Benign Paroxysmal Positional Vertigo, Vertigo and Autonomic Nervous System, sponsored by Clalit Health Services. Completed at 1 site in Israel. Open to participants aged 30 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-13.

Sponsored by Clalit Health Services · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
36
Ages
30 Years to 70 Years
Sex
All
01

Study summary

The vestibular system in the inner year is an important system in the body which is responsible for balance. In addition, there is evidence that the vestibular system plays a role in maintaining blood pressure while changing body position, such as moving from lying down in bed to sitting. Dysfunction of the vestibular system may affect the ability to maintain blood pressure, therefore the aim of this study is to assess if a specific problem in the vestibular system (Benign Paroxysmal Positional Vertigo- BPPV) may cause changes in the interaction between the vestibular system and the cardiovascular system. We assume that patients with this medical condition (BPPV) will have different heart rate parameters in comparison with healthy patients.

Read the detailed description

This is a case-control study, that will consist of one routine assessment by a vestibular physiotherapist in an outpatient clinic in Tel Aviv ("Clalit Health Services"). The session will last approximately 90 minutes, and will include 40-60 participants.

Two groups of patients (30-70 years old) will be assigned to this study:

  1. Patients with Benign Paroxysmal Positional Vertigo (BPPV).
  2. Healthy patients (Control Group).

Both groups will undergo routine physical assessment which is done to diagnose if the patient has BPPV or not. The physical assessment includes quick changes in body and head position.

In addition to the routine physical assessment, heart rate variability parameters will be monitored during the whole session in patients in both groups (using Polar watch RS800CX). Furthermore, all patients will be asked to test their grip strength (using a hand-held dynamometer), moving from sitting to standing 5 times in a row and to fill two questionnaires.

The patients that were diagnosed with BPPV will be treated with the routine vestibular physiotherapy, performed by the same physiotherapist who did the physical assessment.

Statistical analysis of the data will be performed in IBM SPSS Statistics software (version 24), and a statistical significance level of a p-value \< 0.05 will be considered significant. Normality distribution will be tested with the Kolmagorov-Smirnov test.

Parametric tests suitable for the analysis of the data in this study are:

  1. Paired and unpaired t-tests.
  2. Repeated Measures Analysis of Variance (ANOVA).

Non-parametric tests suitable for the analysis of the data in this study are:

  1. Mann-Whitney.
  2. Wilcoxon.

Spearman coefficient will be used to examine correlations.

02

Conditions studied

  • Benign Paroxysmal Positional Vertigo
  • Vertigo
  • Autonomic Nervous System

Keywords

  • Benign Paroxysmal Positional Vertigo
  • BPPV
  • Vertigo
  • Autonomic Nervous System
  • Heart Rate Variability
  • Vestibulo Sympathetic Response
  • Vestibulo Sympathetic Reflex
03

In context

Benign Paroxysmal Positional Vertigo

75 studies on the registry are indexed under Benign Paroxysmal Positional Vertigo; 15 are open to participants now.

This study's enrollment of 36 is below the median of 104 across 11 observational studies indexed under Benign Paroxysmal Positional Vertigo.

Browse Benign Paroxysmal Positional Vertigo studies →

Lead sponsor

Clalit Health Services is the lead sponsor of 44 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with and without BPPV will be recruited to the study in an outpatient physiotherapy clinic (community sample), "Clalit Health Services", in Tel Aviv.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Subjects with BPPV- Patients diagnosed with BPPV, who meet the following criteria:

  1. Main complain of spinning sensation (Vertigo) when changes are made in head position relative to gravity (such as when moving from sitting to lying down or rolling in bed, bending over etc.)
  2. Positive Dix-Hallpike / Supine Roll Test, confirmed by presence of nystagmus.

Subjects without BPPV (Control group):

Subjects who do not suffer from dizziness / spinning sensation (Vertigo).

Exclusion criteria

Exclusion Criteria:

  • Suffering from pain in the day of assessment.
  • Postural Hypotension.
  • Familial Dysautonomia.
  • Diabetic Neuropathy.
  • History of Whiplash or Traumatic Brain Injury (TBI) in the last year.
  • History of Stroke (CVA), Multiple Sclerosis (MS) or Central Positional Vertigo.
  • Coronary Heart Disease (CHD), Cardiac Heart Failure (CHF), Cardiac arrhythmias, Vertebrobasilar Insufficiency (VBI).
  • Under treatment of Beta- Blockers.
  • Anxiety Disorders.
  • Vestibular Migraine, Vestibular Neuritis, Menier's Disease, Perilymphatic Fistula, Superior Canal Dehiscence Syndrome.
  • Medical conditions with high risk of subluxation / dislocation of the Atlanto-axial joint.
  • Health professionals who are specialized to treat Vestibular disorders (such as Vestibular physiotherapists)
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
36 participants (actual)
Patient registry
No

Groups and cohorts

  • Subjects with BPPV

    Patients diagnosed with BPPV, who meet the following criteria: 1. Main complain of spinning sensation (Vertigo) when changes are made in head position relative to gravity. 2. Positive Dix-Hallpike / Supine Roll Test, confirmed by presence of nystagmus.

    Diagnostic Test: Heart rate variability parameters monitoring

  • Subjects without BPPV (Control group)

    Patients who do not suffer from dizziness / spinning sensation (Vertigo), and do not meet the exclusion criteria in the study.

    Diagnostic Test: Heart rate variability parameters monitoring

Interventions

  • Diagnostic testHeart rate variability parameters monitoring

    No intervention- only additional monitoring of heart rate, physical tests and filling of questionnaires: Heart rate variability parameters monitoring- by wearing a Polar watch (RS800CX). Isometric grip test- by using a Jamar Hand Held Dynamometer. Questionnaires: 1. Dizziness Handicap Inventory (DHI) - hebrew version. 2. Stait-Trait Anxiety Inventory (STAI)

    Also known as: Isometric grip test, Five times sit to stand, Questionnaires

06

What researchers measure

Primary outcomes

  1. Heart Rate Variability- SDNN

    Standard Deviation of the Normal to Normal intervals

    Time frame: Through study completion, approximately 1 year

  2. Heart Rate Variability- RMSSD

    Root Mean Square of the Successive Differences

    Time frame: Through study completion, approximately 1 year

Secondary outcomes

  1. Dizziness Handicap Inventory

    Dizziness Handicap Inventory score from the hebrew version of the questionnaire

    Time frame: Through study completion, approximately 1 year

  2. Stait- Trait Anxiety Inventory

    Stait- Trait Anxiety Inventory score from the hebrew version of the questionnaire

    Time frame: Through study completion, approximately 1 year

07

Study locations

1 site
  • Horowitz Physiotherapy Clinic
    Tel Aviv, Israel
08

References and documents

Publications

  • ▪ Bhattacharyya, N., Gubbels, S. P., Schwartz, S. R., Edlow, J. A., El-Kashlan, H., Fife, T., ... & Seidman, M. D. (2017). Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngology-Head and Neck Surgery, 156(3_suppl), S1-S47. ▪ Carter, J. R., & Ray, C. A. (2008). Sympathetic responses to vestibular activation in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 294(3), R681-R688. ▪ Ewing, D. J., & Clarke, B. F. (1982). Diagnosis and management of diabetic autonomic neuropathy. British medical journal (Clinical research ed.), 285(6346), 916. ▪ Ewing, D. J., Irving, J. B., Kerr, F., Wildsmith, J. A. W., & Clarke, B. F. (1974). Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. Clinical Science, 46(3), 295-306. ▪ Fielder, H., Denholm, S. W., Lyons, R. A., & Fielder, C. P. (1996). Measurement of health status in patients with vertigo. Clinical Otolaryngology, 21(2), 124-126. ▪ Jacob, R. G., & Furman, J. M. (2001). Psychiatric consequences of vestibular dysfunction. Current opinion in Neurology, 14(1), 41-46. ▪ Jáuregui-Renaud, K., Aw, S. T., Todd, M. J., McGarvie, L. A., & Halmagyi, G. M. (2005). Benign paroxysmal positional vertigo can interfere with the cardiac response to head-down tilt. Otology & Neurotology, 26(3), 484-488. ▪ Jáuregui-Renaud, K., Hermosillo, A. G., Gómez, A., Márquez, M. F., Cárdenas, M., & Bronstein, A. M. (2003). Autonomic function interferes in cardiovascular reflexes. Archives of medical research, 34(3), 200-204. ▪ Julian, L. J. (2011). Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis care & research, 63(S11). ▪ Kaplan DM, Friger M, Racover NK, Peleg A, Kraus M, Puterman M. [The Hebrew dizziness handicap inventory]. Harefuah. 2010 Nov;149(11):697-700, 750, 749.Hebrew. PubMed PMID: 21250408 ▪ Khurana, R. K., & Setty, A. (1996). The value of the isometric hand-grip test-studies in various autonomic disorders. Clinical Autonomic Research, 6(4), 211-218. ▪ McCall, A. A., Miller, D. M., & Yates, B. J. (2017). Descending influences on vestibulospinal and vestibulosympathetic reflexes. Frontiers in neurology, 8, 112. ▪ Mutlu, B., & Serbetcioglu, B. (2013). Discussion of the dizziness handicap inventory. Journal of Vestibular Research, 23(6), 271-277. ▪ Nussinovitch, U., Elishkevitz, K. P., Katz, K., Nussinovitch, M., Segev, S., Volovitz, B., & Nussinovitch, N. (2011). Reliability of ultra-short ECG indices for heart rate variability. Annals of Noninvasive Electrocardiology, 16(2), 117-122. ▪ Ray, C. A. (2000). Interaction of the vestibular system and baroreflexes on sympathetic nerve activity in humans. American Journal of Physiology-Heart and Circulatory Physiology, 279(5), H2399-H2404. ▪ Schroeder, E. B., Whitsel, E. A., Evans, G. W., Prineas, R. J., Chambless, L. E., & Heiss, G. (2004). Repeatability of heart rate variability measures. Journal of electrocardiology, 37(3), 163-172. ▪ Sztajzel, J. (2004). Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss medical weekly, 134(35-36), 514-522. ▪ Yates, B. J., Bolton, P. S., & Macefield, V. G. (2014). Vestibulo-sympathetic responses. Comprehensive Physiology, 4(2), 851-887. ▪ Yates, B. J., & Bronstein, A. M. (2005). The effects of vestibular system lesions on autonomic regulation: observations, mechanisms, and clinical implications. Journal of Vestibular Research, 15(3), 119-129.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2019 to primary completion in Sep 2020, 16 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2019
First posted
Mar 7, 2019
StartActual
Apr 28, 2019
Primary completionActual
Sep 1, 2020
CompletionActual
Sep 1, 2020
Last update
Jan 13, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03867019
Lead sponsor
Clalit Health Services
Collaborators
Tel Aviv University
Responsible party
Dr. Moshe Chaimoff (Dr. Moshe Chaimoff, Otolaryngology specialist, Principal investigator, Clalit Health Services) — Principal investigator
First posted
Mar 7, 2019
Start date
Apr 28, 2019
Primary completion
Sep 1, 2020
Completion
Sep 1, 2020
Last update
Jan 13, 2021

Study contacts

Moshe Chaimoff, Dr.
principal investigator · Clalit Health Services

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion